President Donald Trump is expected to announce a major expansion of TrumpRX on Monday at 4:30 p.m. at the White House.
The pharmaceutical drug purchasing platform, which Trump launched in early February, previously only sold brand-name drugs from 17 specific manufacturers directly to consumers at a discounted rate. Billionaire Mark Cuban, who owns and operates the online generic pharmaceutical marketplace Cost Plus Drugs, is expected to attend Trump’s announcement.
Cuban announced that Cost Plus Drugs would be collaborating with TrumpRX in late April. Cuban told Fox News at the time that his company would be “integrating” its medication list with the TrumpRX platform.
Trump routinely touts his efforts to lower prescription drug costs, especially his “Most Favored Nations” pricing proposal, for voters, as healthcare and affordability remain top issues heading into the 2026 elections.
